Exciting Opportunity: Join the Ambry Rare Disease Sales Team!
Ambry Genetics Claimed Company
Recently acquired by Tempus Labs, Ambry Genetics excels at translating scientific research into clinically actionable test results based on a deep understanding of the human genome and the biology behind genetic disease. We care about what happens to real people, their families, and the people they love. Our team is dedicated to providing them and their clinicians with deeper knowledge and fresh insights, so together they can make informed, potentially life-altering healthcare decisions. read more
Greg Nogle ā VP, Market Access at Ambry Genetics
Executive Bio
Greg Nogle joined Ambry in 2015 and currently serves as VP of Market Access. In this role, Greg is responsible for integrating coding/coverage initiatives with CMS and Medicare contractors and driving reimbursement strategies for commercial and government payers. He also oversees coverage efforts aligned with clinical affairs to drive policy changes within molecular diagnostics. Greg received his BS in Economics from Louisiana State University.
Executive Team Culture Ratings from Ambry Genetics Employees
TOP
5%
Ambry Genetics' Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Ambry Genetics' Executive Team at a Glance
Based on 1051 ratings, Ambry Genetics' employees are very satisfied with their Executive Team and give them an āA+ā or 85/100. On average, Men provided higher ratings for their Executive Team compared to Women. Also, the Legal department thinks more highly of the Executive Team relative to the Executive department.
Ambry Genetics' Executive Team ranks in the Top 10% of other companies in Los Angeles and Top 5% of other companies on Comparably that also have 501-1,000 Employees.
×